Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.

Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, Carecchio M, Reid E, Heslegrave A, Fenoglio C, Scarpini E, Schott JM, Fox NC, Hardy J, Bhatia K, Heales S, Sebire NJ, Zetterberg H, Mills K.

Mol Neurodegener. 2015 Dec 1;10:64. doi: 10.1186/s13024-015-0059-y. Erratum in: Mol Neurodegener. 2016;11:20. Bahtia, Kailash and Zetterburg, Henrik [Corrected to Bhatia, Kailash and Zetterberg, Henrik].

2.

Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.

Taka E, Mazzio EA, Goodman CB, Redmon N, Flores-Rozas H, Reams R, Darling-Reed S, Soliman KF.

J Neuroimmunol. 2015 Sep 15;286:5-12. doi: 10.1016/j.jneuroim.2015.06.011. Epub 2015 Jun 27.

3.
4.

Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures.

Espinosa-Oliva AM, de Pablos RM, Sarmiento M, Villarán RF, Carrillo-Jiménez A, Santiago M, Venero JL, Herrera AJ, Cano J, Machado A.

Neurotoxicology. 2014 Mar;41:89-101. doi: 10.1016/j.neuro.2014.01.006. Epub 2014 Jan 30.

PMID:
24486959
5.

Expression of integrin and CD44 receptors recognising osteopontin in the normal and LPS-lesioned rat substantia nigra.

Ailane S, Long P, Jenner P, Rose S.

Eur J Neurosci. 2013 Aug;38(3):2468-76. doi: 10.1111/ejn.12231. Epub 2013 May 22.

PMID:
23692556
6.

Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers.

Han YF, Cao GW.

World J Gastroenterol. 2012 Dec 21;18(47):6865-73. doi: 10.3748/wjg.v18.i47.6865.

7.

A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain.

Long P, Samnakay P, Jenner P, Rose S.

Eur J Neurosci. 2012 Sep;36(6):2733-42. doi: 10.1111/j.1460-9568.2012.08189.x. Epub 2012 Jul 11.

PMID:
22779921
8.
9.

Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease.

Ribner A, Altarescu G, Zimran A, Elstein D.

Mov Disord. 2011 Jun;26(7):1341-3. doi: 10.1002/mds.23595. Epub 2011 Apr 5.

PMID:
21469198
10.

The role of osteopontin in neurodegenerative diseases.

Carecchio M, Comi C.

J Alzheimers Dis. 2011;25(2):179-85. doi: 10.3233/JAD-2011-102151. Review.

PMID:
21358042
11.

The RGD-containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra.

Iczkiewicz J, Broom L, Cooper JD, Wong AM, Rose S, Jenner P.

J Neurochem. 2010 Sep;114(6):1792-804. doi: 10.1111/j.1471-4159.2010.06896.x. Epub 2010 Aug 3.

12.

Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions.

Satoh J, Obayashi S, Misawa T, Tabunoki H, Yamamura T, Arima K, Konno H.

Neuropathology. 2008 Dec;28(6):561-76. doi: 10.1111/j.1440-1789.2008.00915.x. Epub 2008 Apr 7.

PMID:
18410276
13.

Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.

Iczkiewicz J, Rose S, Jenner P.

Exp Neurol. 2007 Sep;207(1):95-106. Epub 2007 Jun 18.

PMID:
17643430
14.

Identification of genes related to Parkinson's disease using expressed sequence tags.

Kim JM, Lee KH, Jeon YJ, Oh JH, Jeong SY, Song IS, Kim JM, Lee DS, Kim NS.

DNA Res. 2006 Dec 31;13(6):275-86. Epub 2007 Jan 8.

PMID:
17213182
15.

Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model.

Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C.

Neurobiol Dis. 2007 Mar;25(3):473-82. Epub 2006 Dec 26.

PMID:
17188882
16.

Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease.

Iczkiewicz J, Jackson MJ, Smith LA, Rose S, Jenner P.

Brain Res. 2006 Nov 6;1118(1):239-50. Epub 2006 Sep 7.

PMID:
16962083
17.

Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat.

Iczkiewicz J, Rose S, Jenner P.

Eur J Neurosci. 2005 Apr;21(7):1911-20.

PMID:
15869484
18.

Osteopontin (Eta-1) is present in the rat basal ganglia.

Iczkiewicz J, Rose S, Jenner P.

Brain Res Mol Brain Res. 2004 Dec 6;132(1):64-72.

PMID:
15548430
19.

Immunohistochemical examination on intracranial calcification in neurodegenerative diseases.

Fujita D, Terada S, Ishizu H, Yokota O, Nakashima H, Ishihara T, Kuroda S.

Acta Neuropathol. 2003 Mar;105(3):259-64. Epub 2002 Nov 22.

PMID:
12557013
20.

Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach.

Ragno S, Romano M, Howell S, Pappin DJ, Jenner PJ, Colston MJ.

Immunology. 2001 Sep;104(1):99-108.

Supplemental Content

Loading ...
Support Center